Item 1 - Financial Statements
Uniroyal Global Engineered Products,
Inc.
Consolidated Balance Sheets
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
818,289
|
|
|
$
|
1,028,841
|
|
Accounts receivable, net
|
|
|
13,410,069
|
|
|
|
12,422,330
|
|
Inventories, net
|
|
|
19,293,442
|
|
|
|
19,460,260
|
|
Other current assets
|
|
|
626,065
|
|
|
|
965,520
|
|
Related party receivable
|
|
|
33,217
|
|
|
|
20,118
|
|
Total Current Assets
|
|
|
34,181,082
|
|
|
|
33,897,069
|
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENT, NET
|
|
|
25,177,807
|
|
|
|
18,878,949
|
|
|
|
|
|
|
|
|
|
|
OTHER ASSETS
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
|
3,148,983
|
|
|
|
3,217,997
|
|
Goodwill
|
|
|
1,079,175
|
|
|
|
1,079,175
|
|
Other long-term assets
|
|
|
3,485,996
|
|
|
|
3,693,367
|
|
Total Other Assets
|
|
|
7,714,154
|
|
|
|
7,990,539
|
|
TOTAL ASSETS
|
|
$
|
67,073,043
|
|
|
$
|
60,766,557
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Checks issued in excess of bank balance
|
|
$
|
752,485
|
|
|
$
|
855,210
|
|
Lines of credit
|
|
|
20,936,172
|
|
|
|
19,325,116
|
|
Current maturities of long-term debt
|
|
|
1,502,555
|
|
|
|
1,369,967
|
|
Current maturities of finance lease liabilities
|
|
|
177,190
|
|
|
|
388,862
|
|
Accounts payable
|
|
|
9,332,977
|
|
|
|
9,335,235
|
|
Accrued expenses and other liabilities
|
|
|
4,059,081
|
|
|
|
3,326,291
|
|
Related party obligation
|
|
|
179,858
|
|
|
|
84,154
|
|
Current portion of postretirement benefit liability - health and life
|
|
|
139,095
|
|
|
|
139,095
|
|
Total Current Liabilities
|
|
|
37,079,413
|
|
|
|
34,823,930
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM LIABILITIES
|
|
|
|
|
|
|
|
|
Long-term debt, less current portion
|
|
|
3,462,188
|
|
|
|
3,967,754
|
|
Finance lease liabilities, less current portion
|
|
|
18,477
|
|
|
|
109,446
|
|
Related party lease financing obligation
|
|
|
2,679,989
|
|
|
|
2,613,717
|
|
Long-term debt to related parties
|
|
|
3,190,655
|
|
|
|
2,990,655
|
|
Postretirement benefit liability - health and life, less current portion
|
|
|
2,083,684
|
|
|
|
2,101,892
|
|
Other long-term liabilities
|
|
|
6,531,063
|
|
|
|
653,653
|
|
Total Long-Term Liabilities
|
|
|
17,966,056
|
|
|
|
12,437,117
|
|
Total Liabilities
|
|
|
55,045,469
|
|
|
|
47,261,047
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
Preferred units, Series A UEP Holdings, LLC, 200,000 units issued
and outstanding ($100 issue price)
|
|
|
617,571
|
|
|
|
617,571
|
|
Preferred units, Series B UEP Holdings, LLC, 150,000 units issued
and outstanding ($100 issue price)
|
|
|
463,179
|
|
|
|
463,179
|
|
Preferred stock, Uniroyal Global (Europe) Limited, 50 shares
issued and outstanding ($1.51 stated value)
|
|
|
75
|
|
|
|
75
|
|
Common stock, 95,000,000 shares authorized ($.001 par value)
18,680,030 and 18,690,030 shares issued and outstanding as of
September 29, 2019 and December 30, 2018, respectively
|
|
|
18,680
|
|
|
|
18,690
|
|
Additional paid-in capital
|
|
|
35,275,646
|
|
|
|
35,244,770
|
|
Accumulated deficit
|
|
|
(23,202,469
|
)
|
|
|
(22,136,130
|
)
|
Accumulated other comprehensive loss
|
|
|
(1,145,108
|
)
|
|
|
(702,645
|
)
|
Total Stockholders' Equity
|
|
|
12,027,574
|
|
|
|
13,505,510
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
67,073,043
|
|
|
$
|
60,766,557
|
|
See accompanying
notes to the consolidated financial statements.
Uniroyal Global Engineered Products,
Inc.
Consolidated Statements of Operations
(Unaudited)
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET SALES
|
|
$
|
22,033,539
|
|
|
$
|
24,322,532
|
|
|
$
|
71,523,182
|
|
|
$
|
76,775,452
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF GOODS SOLD
|
|
|
18,471,639
|
|
|
|
20,112,796
|
|
|
|
59,434,689
|
|
|
|
63,184,044
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
3,561,900
|
|
|
|
4,209,736
|
|
|
|
12,088,493
|
|
|
|
13,591,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
1,061,781
|
|
|
|
1,075,064
|
|
|
|
3,348,622
|
|
|
|
3,624,145
|
|
General and administrative
|
|
|
1,373,118
|
|
|
|
1,587,656
|
|
|
|
4,332,978
|
|
|
|
5,194,622
|
|
Research and development
|
|
|
377,989
|
|
|
|
408,256
|
|
|
|
1,302,707
|
|
|
|
1,260,784
|
|
Other operating expenses
|
|
|
-
|
|
|
|
-
|
|
|
|
343,003
|
|
|
|
-
|
|
OPERATING EXPENSES
|
|
|
2,812,888
|
|
|
|
3,070,976
|
|
|
|
9,327,310
|
|
|
|
10,079,551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
|
|
|
749,012
|
|
|
|
1,138,760
|
|
|
|
2,761,183
|
|
|
|
3,511,857
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER EXPENSE:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other debt related expense
|
|
|
(509,829
|
)
|
|
|
(488,905
|
)
|
|
|
(1,547,343
|
)
|
|
|
(1,418,932
|
)
|
Other income (expense)
|
|
|
50,213
|
|
|
|
(22,956
|
)
|
|
|
53,396
|
|
|
|
(8,894
|
)
|
Net Other Expense
|
|
|
(459,616
|
)
|
|
|
(511,861
|
)
|
|
|
(1,493,947
|
)
|
|
|
(1,427,826
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME BEFORE TAX PROVISION
|
|
|
289,396
|
|
|
|
626,899
|
|
|
|
1,267,236
|
|
|
|
2,084,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TAX PROVISION (BENEFIT)
|
|
|
12,022
|
|
|
|
(132,670
|
)
|
|
|
(6,287
|
)
|
|
|
(89,670
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
|
277,374
|
|
|
|
759,569
|
|
|
|
1,273,523
|
|
|
|
2,173,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock dividend
|
|
|
(777,372
|
)
|
|
|
(769,687
|
)
|
|
|
(2,339,862
|
)
|
|
|
(2,330,250
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS ALLOCABLE TO COMMON
SHAREHOLDERS
|
|
$
|
(499,998
|
)
|
|
$
|
(10,118
|
)
|
|
$
|
(1,066,339
|
)
|
|
$
|
(156,549
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.03
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.01
|
)
|
Diluted
|
|
$
|
(0.03
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.01
|
)
|
WEIGHTED AVERAGE SHARES OUTSTANDING:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
18,680,030
|
|
|
|
18,690,030
|
|
|
|
18,684,938
|
|
|
|
18,690,030
|
|
Diluted
|
|
|
18,680,030
|
|
|
|
18,690,030
|
|
|
|
18,684,938
|
|
|
|
18,690,030
|
|
See accompanying notes to the consolidated financial statements.
Uniroyal Global Engineered Products,
Inc.
Consolidated Statements of Comprehensive
Loss
(Unaudited)
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
$
|
277,374
|
|
|
$
|
759,569
|
|
|
$
|
1,273,523
|
|
|
$
|
2,173,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER COMPREHENSIVE LOSS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum benefit liability adjustment
|
|
|
(73,617
|
)
|
|
|
(29,931
|
)
|
|
|
(220,851
|
)
|
|
|
(89,393
|
)
|
Foreign currency translation adjustment
|
|
|
(240,059
|
)
|
|
|
(65,932
|
)
|
|
|
(221,612
|
)
|
|
|
(358,910
|
)
|
OTHER COMPREHENSIVE LOSS
|
|
|
(313,676
|
)
|
|
|
(95,863
|
)
|
|
|
(442,463
|
)
|
|
|
(448,303
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME (LOSS)
|
|
|
(36,302
|
)
|
|
|
663,706
|
|
|
|
831,060
|
|
|
|
1,725,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock dividend
|
|
|
(777,372
|
)
|
|
|
(769,687
|
)
|
|
|
(2,339,862
|
)
|
|
|
(2,330,250
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE LOSS TO COMMON
SHAREHOLDERS
|
|
$
|
(813,674
|
)
|
|
$
|
(105,981
|
)
|
|
$
|
(1,508,802
|
)
|
|
$
|
(604,852
|
)
|
See accompanying notes to the consolidated financial statements.
Uniroyal Global Engineered Products,
Inc.
Consolidated Statements of Changes in
Stockholders' Equity
(Unaudited)
|
|
|
UEPH
Series A
|
|
|
|
UEPH
Series B
|
|
|
|
UGEL
Preferred
|
|
|
|
Common
Stock
|
|
|
|
Additional
Paid In
|
|
|
|
Accumulated
|
|
|
|
Accumulated
Other
Comprehensive
|
|
|
|
|
|
|
|
|
Units
|
|
|
|
Amount
|
|
|
|
Units
|
|
|
|
Amount
|
|
|
|
Shares
|
|
|
|
Amount
|
|
|
|
Shares
|
|
|
|
Amount
|
|
|
|
Capital
|
|
|
|
Deficit
|
|
|
|
Loss
|
|
|
|
Total
Equity
|
|
For the Three Months Ended
|
|
|
|
|
|
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance July 1, 2018
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,690,030
|
|
|
$
|
18,690
|
|
|
$
|
35,138,353
|
|
|
$
|
(20,423,375
|
)
|
|
$
|
(727,592
|
)
|
|
$
|
15,086,901
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
759,569
|
|
|
|
-
|
|
|
|
759,569
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(95,863
|
)
|
|
|
(95,863
|
)
|
Stock-based compensation
expense
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
62,250
|
|
|
|
-
|
|
|
|
-
|
|
|
|
62,250
|
|
Preferred stock dividend
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(769,687
|
)
|
|
|
-
|
|
|
|
(769,687
|
)
|
Balance September 30, 2018
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,690,030
|
|
|
$
|
18,690
|
|
|
$
|
35,200,603
|
|
|
$
|
(20,433,493
|
)
|
|
$
|
(823,455
|
)
|
|
$
|
15,043,170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 29, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance June 30, 2019
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,680,030
|
|
|
$
|
18,680
|
|
|
$
|
35,275,646
|
|
|
$
|
(22,702,471
|
)
|
|
$
|
(831,432
|
)
|
|
$
|
12,841,248
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
277,374
|
|
|
|
-
|
|
|
|
277,374
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(313,676
|
)
|
|
|
(313,676
|
)
|
Preferred stock dividend
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(777,372
|
)
|
|
|
-
|
|
|
|
(777,372
|
)
|
Balance September 29, 2019
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,680,030
|
|
|
$
|
18,680
|
|
|
$
|
35,275,646
|
|
|
$
|
(23,202,469
|
)
|
|
$
|
(1,145,108
|
)
|
|
$
|
12,027,574
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2017
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,690,030
|
|
|
$
|
18,690
|
|
|
|
34,944,972
|
|
|
$
|
(20,276,944
|
)
|
|
$
|
(375,152
|
)
|
|
$
|
15,392,391
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,173,701
|
|
|
|
-
|
|
|
|
2,173,701
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(448,303
|
)
|
|
|
(448,303
|
)
|
Stock-based compensation
expense
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
255,631
|
|
|
|
-
|
|
|
|
-
|
|
|
|
255,631
|
|
Preferred stock dividend
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,330,250
|
)
|
|
|
-
|
|
|
|
(2,330,250
|
)
|
Balance September 30, 2018
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,690,030
|
|
|
$
|
18,690
|
|
|
$
|
35,200,603
|
|
|
$
|
(20,433,493
|
)
|
|
$
|
(823,455
|
)
|
|
$
|
15,043,170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 29, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 30, 2018
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,690,030
|
|
|
$
|
18,690
|
|
|
$
|
35,244,770
|
|
|
$
|
(22,136,130
|
)
|
|
$
|
(702,645
|
)
|
|
$
|
13,505,510
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,273,523
|
|
|
|
-
|
|
|
|
1,273,523
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(442,463
|
)
|
|
|
(442,463
|
)
|
Stock-based compensation
expense
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
44,166
|
|
|
|
-
|
|
|
|
-
|
|
|
|
44,166
|
|
Treasury shares purchased at
cost
and retired
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(10,000
|
)
|
|
|
(10
|
)
|
|
|
(13,290
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(13,300
|
)
|
Preferred stock dividend
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,339,862
|
)
|
|
|
-
|
|
|
|
(2,339,862
|
)
|
Balance September 29, 2019
|
|
|
200,000
|
|
|
$
|
617,571
|
|
|
|
150,000
|
|
|
$
|
463,179
|
|
|
|
50
|
|
|
$
|
75
|
|
|
|
18,680,030
|
|
|
$
|
18,680
|
|
|
$
|
35,275,646
|
|
|
$
|
(23,202,469
|
)
|
|
$
|
(1,145,108
|
)
|
|
$
|
12,027,574
|
|
See accompanying notes to the consolidated financial statements.
Uniroyal Global Engineered Products,
Inc.
Consolidated Statements of Cash Flows
(Unaudited)
|
|
Nine Months Ended
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,273,523
|
|
|
$
|
2,173,701
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
1,778,280
|
|
|
|
1,620,069
|
|
Stock-based compensation expense
|
|
|
44,166
|
|
|
|
255,631
|
|
Amortization of intangible assets
|
|
|
12,917
|
|
|
|
18,753
|
|
Loss on disposal of property and equipment
|
|
|
68,395
|
|
|
|
48,380
|
|
Noncash postemployment health and life benefit
|
|
|
(220,851
|
)
|
|
|
(89,393
|
)
|
Noncash lease expense
|
|
|
(26,258
|
)
|
|
|
-
|
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(1,187,917
|
)
|
|
|
(164,748
|
)
|
Inventories
|
|
|
(82,294
|
)
|
|
|
132,267
|
|
Other current assets
|
|
|
324,711
|
|
|
|
(13,552
|
)
|
Related party receivable
|
|
|
(13,099
|
)
|
|
|
(13,107
|
)
|
Other long-term assets
|
|
|
74,135
|
|
|
|
51,740
|
|
Accounts payable
|
|
|
185,837
|
|
|
|
625,564
|
|
Accrued expenses and other liabilities
|
|
|
249,784
|
|
|
|
431,754
|
|
Postretirement benefit liability - health and life
|
|
|
(18,208
|
)
|
|
|
(38,302
|
)
|
Other long-term liabilities
|
|
|
(7,244
|
)
|
|
|
(117,935
|
)
|
Cash provided by operating activities
|
|
|
2,455,877
|
|
|
|
4,920,822
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(1,584,511
|
)
|
|
|
(3,063,256
|
)
|
Payments on life insurance policies, net of proceeds from policy loans
|
|
|
127,440
|
|
|
|
(122,299
|
)
|
Cash used in investing activities
|
|
|
(1,457,071
|
)
|
|
|
(3,185,555
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Net change in checks issued in excess of bank balance
|
|
|
(102,725
|
)
|
|
|
44,436
|
|
Net advances on lines of credit
|
|
|
1,893,069
|
|
|
|
936,673
|
|
Payments on long-term debt
|
|
|
(959,539
|
)
|
|
|
(924,382
|
)
|
Proceeds from issuance of long-term debt
|
|
|
454,088
|
|
|
|
560,677
|
|
Payments on finance lease liabilities
|
|
|
(297,676
|
)
|
|
|
(304,383
|
)
|
Additions to related party obligation
|
|
|
800,000
|
|
|
|
272,000
|
|
Payments on related party obligation
|
|
|
(628,023
|
)
|
|
|
(67,502
|
)
|
Payment of preferred stock dividends
|
|
|
(2,332,503
|
)
|
|
|
(2,325,640
|
)
|
Purchase and retirement of treasury stock
|
|
|
(13,300
|
)
|
|
|
-
|
|
Cash used in financing activities
|
|
|
(1,186,609
|
)
|
|
|
(1,808,121
|
)
|
Net change in cash and cash equivalents
|
|
|
(187,803
|
)
|
|
|
(72,854
|
)
|
Cash and cash equivalents - beginning of period
|
|
|
1,028,841
|
|
|
|
1,267,319
|
|
Effects of currency translation on cash and cash equivalents
|
|
|
(22,749
|
)
|
|
|
(25,163
|
)
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
|
$
|
818,289
|
|
|
$
|
1,169,302
|
|
See Note 2 for noncash transactions and supplemental disclosure of cash flow information.
See accompanying notes to the consolidated financial statements.
UNIROYAL GLOBAL ENGINEERED PRODUCTS,
INC.
Notes to Consolidated Financial Statements
September 29, 2019
(Unaudited)
The accompanying unaudited interim
consolidated financial statements have been prepared based upon U.S. Securities and Exchange Commission rules that permit reduced
disclosure for interim periods. Therefore, they do not include all information and footnote disclosures necessary for a complete
presentation of Uniroyal Global Engineered Products, Inc.’s financial position, results of operations and cash flows, in
conformity with generally accepted accounting principles. Uniroyal Global Engineered Products, Inc. (the “Company,”
“Uniroyal Global,” “we,” or “us”) filed audited consolidated financial statements as of and
for the fiscal years ended December 30, 2018 and December 31, 2017 which included all information and notes necessary for such
complete presentation in conjunction with its 2018 Annual Report on Form 10-K.
The results of operations for
the interim period ended September 29, 2019 are not necessarily indicative of the results to be expected for any future period
or the entire fiscal year. These interim consolidated financial statements should be read in conjunction with the audited consolidated
financial statements for the year ended December 30, 2018, which are contained in the Company’s 2018 Annual Report on Form
10-K.
The Company owns all of the
ownership interests in Uniroyal Engineered Products, LLC (“Uniroyal”) and its holding company UEP Holdings, LLC (“UEPH”),
a U.S. manufacturer of textured coatings, and all of the ordinary common stock of Uniroyal Global (Europe) Limited (“UGEL”)
formerly known as Engineered Products Acquisition Limited (“EPAL”), the holding company for Uniroyal Global Limited
(“UGL”) formerly Wardle Storeys (Earby) Limited (“Wardle Storeys”), a European manufacturer of textured
coatings and polymer films.
The Company and its subsidiaries
use a 52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending December 29, 2019 and the prior
year ended December 30, 2018 are 52-week years.
The accompanying unaudited
interim consolidated financial statements contain all adjustments (consisting of normal recurring items) which are, in the opinion
of management, necessary for a fair presentation of the Company’s financial position as of September 29, 2019 and the results
of operations, comprehensive loss and cash flows for the interim periods ended September 29, 2019 and September 30, 2018.
The unaudited interim consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The
financial position and results of operations of the Company’s U.K.-based operations are measured using the British Pound
Sterling as the functional currency. See Note 5, Foreign Currency Translation.
For purposes of comparability,
certain reclassifications have been made to amounts previously reported to conform with the current period presentation.
|
2.
|
Noncash Transactions and Supplemental Disclosure of Cash Flow Information
|
During the nine months ended
September 29, 2019 and September 30, 2018, the Company entered into several equipment financing obligations with fair values of
$379,126 and $793,001, respectively, which are accounted for as capital assets. The fair values were added to property and equipment
and a corresponding amount to finance lease or long-term debt. See Note 12 for additional information on finance leases.
The Company adopted Accounting
Standards Update (“ASU”) No. 2016-02, “Leases” on December 31, 2018. Under this new standard, the Company
was required to record on its balance sheet previously unrecorded operating leases based on the present value of remaining lease
payments. Per this new standard, the Company recorded right-of-use (“ROU”) operating lease assets and operating lease
liabilities of $6,815,376 on its consolidated balance sheet as of December 31, 2018. During the nine months ended September 29,
2019, the Company recorded new lease ROU operating lease assets and operating lease liabilities of $287,828, amortization of its
ROU operating lease assets of $457,692 and amortization of its operating lease liabilities of $483,950. See Note 12 for additional
information on operating leases.
During the third quarter of
2019, the Company obtained $249,051 in loans against the cash value of its company owned life insurance policies and are shown
net of payments of $121,611 on the life insurance policies in the consolidated statements of cash flows. These loans have a weighted
average interest rate of 3.66% and can be repaid at any time.
On April 1, 2018, the Company’s
majority shareholder purchased the company owned life insurance policy on his life. The policy had a net value of $128,399 based
on the cash surrender value of $578,490 and a policy loan outstanding in the amount of $450,091. After his assumption of a related
party demand note payable in the amount of $125,000, the balance due of $3,399 was paid on April 17, 2018.
Supplemental disclosure of cash paid for the nine
months ended:
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
|
|
|
|
|
|
Interest expense
|
|
$
|
1,452,735
|
|
|
$
|
1,344,520
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
-
|
|
|
$
|
-
|
|
The Company recognizes all of
its derivative instruments as either assets or liabilities in the consolidated balance sheet at fair value. The accounting for
changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging
relationship and further, as to whether the hedge is a cash flow hedge or a fair value hedge.
The Company incurs foreign currency
risk on sales and purchases denominated in other currencies, primarily the British Pound Sterling and the Euro. Foreign currency
exchange contracts are used by the Company principally to limit the exchange rate fluctuations of the Euro. The Euro risk is partially
limited due to natural cash flow offsets. Currency exchange contracts are purchased for approximately 25% of the net risk. These
contracts are not designated as cash flow hedges for accounting purposes. Changes in fair value of these contracts are reported
in Other Income (Expense) in the accompanying consolidated statements of operations.
|
4.
|
Fair Value of Financial
Instruments
|
The Company’s short-term
financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and lines of credit. The Company
adjusts the carrying value of financial instruments denominated in other currencies such as cash, receivables, accounts payable
and lines of credit using the appropriate exchange rates at the balance sheet date. The Company believes that the carrying values
of these short-term financial instruments approximate their estimated fair values.
The fair value of the Company’s
long-term debt is estimated based on current rates for similar instruments with the same remaining maturities. In determining the
current interest rates for similar instruments, the Company takes into account its risk of nonperformance. The Company believes
that the carrying value of its long-term debt approximates its estimated fair value.
The Company uses foreign currency
exchange contracts which are recorded at their estimated fair values in the accompanying consolidated balance sheets. The fair
values of the contracts at September 29, 2019 and December 30, 2018 were a net liability of $931 and $26,814, respectively, included
in other current liabilities. The fair values of the currency exchange contracts are based upon observable market transactions
of spot and forward rates.
For the nine months ended September
29, 2019, there have been no changes in the application of valuation methods applied to similar assets and liabilities.
|
5.
|
Foreign Currency Translation
|
The financial position and results
of operations of the Company’s foreign subsidiaries are measured using the local currency as the functional currency. Assets
and liabilities of operations denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at
the balance sheet date, while the capital accounts are translated at the historical rate for the date they were recognized. Revenues
and expenses are translated at the weighted average exchange rates during the reporting period. The resulting translation gains
and losses on assets and liabilities are recorded in accumulated other comprehensive loss and are excluded from net income until
realized through a sale or liquidation of the investment. Transaction gains and losses generated from the remeasurement of assets
and liabilities denominated in currencies other than the functional currency of the Company’s foreign operations are included
in Other Income (Expense) in the accompanying consolidated statements of operations.
Inventories consist of the following:
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
|
|
|
|
|
|
|
Raw materials
|
|
$
|
6,228,673
|
|
|
$
|
5,863,762
|
|
Work-in-process
|
|
|
4,706,757
|
|
|
|
5,040,582
|
|
Finished goods
|
|
|
10,009,870
|
|
|
|
10,049,567
|
|
|
|
|
20,945,300
|
|
|
|
20,953,911
|
|
Less: Allowance for inventory obsolescence
|
|
|
(1,651,858
|
)
|
|
|
(1,493,651
|
)
|
|
|
|
|
|
|
|
|
|
Total Inventories, net
|
|
$
|
19,293,442
|
|
|
$
|
19,460,260
|
|
|
7.
|
Other Long-term Assets
|
Other long-term assets consist
of the following:
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
|
|
|
|
|
|
|
Deferred tax asset
|
|
$
|
2,859,409
|
|
|
$
|
2,899,634
|
|
Other
|
|
|
626,587
|
|
|
|
793,733
|
|
|
|
|
|
|
|
|
|
|
Total Other Long-term Assets
|
|
$
|
3,485,996
|
|
|
$
|
3,693,367
|
|
|
8.
|
Other Long-term Liabilities
|
Other long-term liabilities
consist of the following:
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
|
|
|
|
|
|
|
Deferred tax liability
|
|
$
|
620,693
|
|
|
$
|
640,219
|
|
Operating lease liabilities
|
|
|
5,903,344
|
|
|
|
-
|
|
Other
|
|
|
7,026
|
|
|
|
13,434
|
|
|
|
|
|
|
|
|
|
|
Total Other Long-term Liabilities
|
|
$
|
6,531,063
|
|
|
$
|
653,653
|
|
See Note 12 for additional
information on operating lease liabilities.
The Company’s Uniroyal
subsidiary has available a $30,000,000 revolving line of credit financing agreement with Wells Fargo Capital Finance, LLC (“Uniroyal
Line of Credit”), which matures on June 15, 2023. Interest is payable monthly at the Eurodollar rate plus 2.25% or Wells
Fargo Capital Finance, LLC's prime rate at the Company's election on outstanding balances up to $6,000,000 and prime rate on amounts
in excess of $6,000,000. Borrowings on the line of credit are subject to the underlying borrowing base specified in the agreement.
The underlying borrowing base is currently determined based upon eligible accounts receivable, inventories and equipment. The line
of credit is secured by substantially all of Uniroyal's assets and includes certain financial and restrictive covenants. The Company
was in compliance with these covenants as of September 29, 2019.
The outstanding balance on the
Uniroyal Line of Credit was $11,668,852 and $10,713,318 as of September 29, 2019 and December 30, 2018, respectively. The Company
has classified the outstanding balance on this line of credit within current liabilities in the accompanying consolidated balance
sheets.
The Company’s U.K. subsidiary
has available a £10,000,000 (approximately $12.3 million) revolving line of credit financing agreement with Lloyds Bank Commercial
Finance Limited (“U.K. Line of Credit”), which is subject to a six-month notice by either party. The line has several
tranches based on currency or underlying security. Interest is payable monthly at the base rate (U.K. LIBOR or Lloyds Bank Base
Rate as published) plus 1.95% to 2.45% depending on the tranche. Borrowings on the line of credit are subject to the underlying
borrowing base specified in the agreement. The underlying borrowing base is currently determined based upon eligible accounts receivable
and inventories. The line of credit is secured by substantially all of the subsidiary's assets and includes certain financial and
restrictive covenants. The Company was in compliance with these covenants as of September 29, 2019.
The outstanding balance on the U.K. Line of Credit
was £7,523,861 and £6,787,260 ($9,267,320 and $8,611,798) as of September 29, 2019 and December 30, 2018, respectively.
The Company has classified the outstanding balance on this line of credit within current liabilities in the accompanying consolidated
balance sheets.
Long-term debt consists of the
following:
|
|
Interest Rate
|
|
|
September 29,
2019
|
|
|
December 30,
2018
|
|
|
|
|
|
|
|
|
|
|
|
Wells Fargo Capital Finance, LLC
|
|
|
Prime
|
|
|
$
|
1,178,251
|
|
|
$
|
1,413,898
|
|
Kennet Equipment Leasing Limited
|
|
|
10.90%
|
|
|
|
279,675
|
|
|
|
451,173
|
|
Regents Capital Corporation
|
|
|
6.20%-7.41%
|
|
|
|
1,102,711
|
|
|
|
1,058,305
|
|
De Lage Landen Financial Services
|
|
|
7.35%
|
|
|
|
49,895
|
|
|
|
68,208
|
|
Ford Motor Credit
|
|
|
4.31%
|
|
|
|
21,042
|
|
|
|
27,881
|
|
Byline Financial Group
|
|
|
8.55%
|
|
|
|
-
|
|
|
|
5,913
|
|
BB&T Equipment Finance Corporation
|
|
|
4.02%-5.12%
|
|
|
|
724,509
|
|
|
|
879,600
|
|
Crown Credit Company
|
|
|
7.06%
|
|
|
|
12,194
|
|
|
|
-
|
|
Lloyds Bank Commercial Finance Limited
|
|
|
LIBOR + 3.15% - +3.50%
|
|
|
|
230,076
|
|
|
|
14,380
|
|
Lloyds Bank Commercial Finance Limited
|
|
|
LIBOR + 3.50%
|
|
|
|
1,305,486
|
|
|
|
1,344,801
|
|
Lloyds Bank Commercial Finance Limited
|
|
|
4.23%
|
|
|
|
60,904
|
|
|
|
73,562
|
|
|
|
|
|
|
|
|
4,964,743
|
|
|
|
5,337,721
|
|
Less: Current portion
|
|
|
|
|
|
|
(1,502,555
|
)
|
|
|
(1,369,967
|
)
|
Long-term Portion
|
|
|
|
|
|
$
|
3,462,188
|
|
|
$
|
3,967,754
|
|
|
11.
|
Related Party Obligations
|
Long-term debt to related parties consists of the
following:
|
|
Interest Rate
|
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
Senior subordinated promissory note
|
|
|
9.25%
|
|
|
$
|
2,000,000
|
|
|
$
|
2,000,000
|
|
Senior secured promissory note
|
|
|
10.00%
|
|
|
|
765,655
|
|
|
|
765,655
|
|
Subordinated secured promissory note
|
|
|
8.00%
|
|
|
|
225,000
|
|
|
|
225,000
|
|
Subordinated secured promissory note
|
|
|
8.00%
|
|
|
|
200,000
|
|
|
|
-
|
|
|
|
|
|
|
|
|
3,190,655
|
|
|
|
2,990,655
|
|
Less: Current portion
|
|
|
|
|
|
|
-
|
|
|
|
-
|
|
Long-term Portion
|
|
|
|
|
|
$
|
3,190,655
|
|
|
$
|
2,990,655
|
|
The Company has a lease financing
obligation under which it leases its main U.S. manufacturing facility and certain other property from a related party lessor entity,
owned by the Company’s majority shareholder. The lease financing obligation accrues interest at 14.95% and currently requires
monthly principal and interest payments of $45,201, which are adjusted annually based on the consumer price index. The lease financing
obligation matures on October 31, 2033. The Company has security deposits aggregating $267,500 held by the lessor entity.
The lease financing obligation
consists of the following:
|
|
September 29, 2019
|
|
|
December 30, 2018
|
|
|
|
|
|
|
|
|
Related party lease financing obligation
|
|
$
|
2,809,847
|
|
|
$
|
2,697,871
|
|
Less: Current portion
|
|
|
(129,858
|
)
|
|
|
(84,154
|
)
|
|
|
|
|
|
|
|
|
|
Long-term Portion
|
|
$
|
2,679,989
|
|
|
$
|
2,613,717
|
|
The long-term portion of the
lease financing obligation is shown in the accompanying consolidated balance sheets as Related Party Lease Financing Obligation.
In July 2019, the Company issued
$600,000 of subordinated secured promissory notes to the Company’s majority shareholder at a rate of 10%. Of these notes,
$550,000 was repaid in September 2019 while the remaining $50,000 balance was repaid in October 2019. The remaining balance of
the related party subordinated secured promissory notes and the current portion of the related party lease financing obligation
total $179,858 and are shown in current liabilities as Related Party Obligation.
During October 2019, the Company
issued a $350,000 subordinated secured promissory note to the Company’s majority shareholder at a rate of 10%.
The Company has operating leases
for equipment and office facilities and finance leases for equipment. These leases expire at various dates from January 2020 through
March 2039. Operating lease right-of-use assets are included in property and equipment, the current portion of operating lease
liabilities is included in accrued expenses and other liabilities, and the long-term portion of operating lease liabilities is
included in other long-term liabilities in the accompanying consolidated balance sheet at September 29, 2019. Finance lease right-of-use
assets are included in property and equipment, the current portion of finance lease liabilities is included in current maturities
of finance lease liabilities, and the long-term portion of finance liabilities is included in finance lease liabilities, less current
portion in the accompanying consolidated balance sheet at September 29, 2019.
The Company determines if an
arrangement is a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset for the
lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating
lease right-of-use assets and liabilities are recognized at the beginning date of a lease based on the present value of lease payments
over the lease term. The Company uses its incremental borrowing rate based on information that is available at the beginning date
of a lease to determine the present value of lease payments, since its leases generally do not provide an implicit rate. The implicit
rate is used when readily determinable. The terms of the Company’s leases may include options to extend or terminate a lease
when it is reasonably certain that the Company will exercise that option. The Company’s lease agreements with lease and non-lease
components are accounted for separately.
The components of lease expense
for the three and nine months ended September 29, 2019 are as follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29, 2019
|
|
|
September 29, 2019
|
|
|
|
|
|
|
|
|
Operating lease expense
|
|
$
|
285,732
|
|
|
$
|
849,936
|
|
|
|
|
|
|
|
|
|
|
Finance lease expense:
|
|
|
|
|
|
|
|
|
Amortization of right-of-use assets
|
|
$
|
36,532
|
|
|
$
|
113,837
|
|
Interest on lease liabilities
|
|
|
3,255
|
|
|
|
14,291
|
|
Total finance lease expense
|
|
$
|
39,787
|
|
|
$
|
128,128
|
|
Cash paid for amounts included in the measurement of lease liabilities
for the three and nine months ended September 29, 2019 are as follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29, 2019
|
|
|
September 29, 2019
|
|
|
|
|
|
|
|
|
Operating cash flows from operating leases
|
|
$
|
135,454
|
|
|
$
|
633,267
|
|
Operating cash flows from finance leases
|
|
$
|
3,255
|
|
|
$
|
14,291
|
|
Financing cash flows from finance leases
|
|
$
|
93,966
|
|
|
$
|
297,676
|
|
Right-of-use assets obtained in exchange for lease
obligations for the three and nine months ended September 29, 2019 are as follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29, 2019
|
|
|
September 29, 2019
|
|
|
|
|
|
|
|
|
Operating leases
|
|
$
|
-
|
|
|
$
|
287,828
|
|
Financing leases
|
|
$
|
-
|
|
|
$
|
-
|
|
Supplemental balance sheet and other information
related to operating leases are as follows:
|
|
September
29, 2019
|
|
Operating leases:
|
|
|
|
|
Property and equipment, net
|
|
$
|
6,461,639
|
|
Accrued expenses and other liabilities
|
|
$
|
532,884
|
|
Other long-term liabilities
|
|
|
5,903,344
|
|
Total operating lease liabilities
|
|
$
|
6,436,228
|
|
Weighted average remaining lease term
|
|
|
15.6 years
|
|
Weighted average discount rate
|
|
|
7.11%
|
|
Supplemental balance sheet and other information
related to finance leases are as follows:
|
|
September 29, 2019
|
|
Finance leases:
|
|
|
|
|
Property and equipment, net
|
|
$
|
1,279,513
|
|
Current maturities of finance lease liabilities
|
|
$
|
177,190
|
|
Finance lease liabilities, less current portion
|
|
|
18,477
|
|
Total finance lease liabilities
|
|
$
|
195,667
|
|
Weighted average remaining lease term
|
|
|
0.9 year
|
|
Weighted average discount rate
|
|
|
5.99%
|
|
Maturities of operating and finance lease
liabilities as of September 29, 2019 are as follows:
|
|
Operating Leases
|
|
|
Finance Leases
|
|
Due in one year or less
|
|
$
|
965,345
|
|
|
$
|
181,081
|
|
Due after one year through two years
|
|
|
850,387
|
|
|
|
18,805
|
|
Due after two years through three years
|
|
|
802,196
|
|
|
|
-
|
|
Due after three years through four years
|
|
|
686,813
|
|
|
|
-
|
|
Due after four years through five years
|
|
|
497,887
|
|
|
|
-
|
|
Thereafter
|
|
|
7,653,201
|
|
|
|
-
|
|
Total lease payments
|
|
|
11,455,829
|
|
|
|
199,886
|
|
Less: Interest
|
|
|
(5,019,601
|
)
|
|
|
(4,219
|
)
|
Total
|
|
$
|
6,436,228
|
|
|
$
|
195,667
|
|
|
13.
|
Accumulated Other Comprehensive
Loss
|
The changes in accumulated other
comprehensive loss were as follows:
|
|
Minimum
Benefit Liability
Adjustments
|
|
|
Foreign Currency
Translation
Adjustment
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 30, 2018
|
|
$
|
836,593
|
|
|
$
|
(1,539,238
|
)
|
|
$
|
(702,645
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss before
reclassifications
|
|
|
-
|
|
|
|
(221,612
|
)
|
|
|
(221,612
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification adjustment for gains included
in net income
|
|
|
(220,851
|
)
|
|
|
-
|
|
|
|
(220,851
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at September 29, 2019
|
|
$
|
615,742
|
|
|
$
|
(1,760,850
|
)
|
|
$
|
(1,145,108
|
)
|
The gains reclassified from accumulated other comprehensive
loss are recorded to the following line items in the consolidated statements of operations:
Other Comprehensive Loss Component
|
|
Consolidated Statements of
Operations Line Item
|
|
|
|
Minimum Benefit Liability Adjustments
|
|
General and administrative expense
|
|
14.
|
Stock Based Compensation
|
On June 25, 2015, the Company’s
stockholders approved the adoption of the 2015 Stock Option Plan. This plan provides for the granting of options to purchase the
Company’s common stock to employees and directors. The options granted are subject to a vesting schedule as set forth in
each individual option agreement. Each option expires on the tenth anniversary of its date of grant unless an earlier termination
date is provided in the grant agreement. The maximum aggregate number of shares of common stock that may be optioned and sold under
the plan shall be 6% of the shares outstanding on the date of grant. The shares that may be optioned under the plan may be authorized
but unissued or may be treasury shares.
Compensation expense is recognized
on a straight-line basis over a three-year vesting period from date of grant.
Stock option activity for the nine
months ended September 29, 2019 and September 30, 2018 is as follows:
|
|
Stock Options
|
|
|
|
|
Total
|
|
|
|
Weighted
Average
Exercise
Price
|
|
|
|
Exercisable
|
|
|
|
Weighted
Average
Exercise
Price
|
|
|
|
Non-
Vested
|
|
|
|
Weighted
Average
Exercise
Price
|
|
Outstanding at December 31, 2017
|
|
|
961,500
|
|
|
$
|
2.80
|
|
|
|
527,165
|
|
|
$
|
2.63
|
|
|
|
434,335
|
|
|
$
|
3.00
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Vested
|
|
|
-
|
|
|
|
-
|
|
|
|
315,504
|
|
|
|
2.80
|
|
|
|
(315,504
|
)
|
|
|
2.80
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Forfeited or cancelled
|
|
|
(15,000
|
)
|
|
|
2.77
|
|
|
|
(8,334
|
)
|
|
|
2.61
|
|
|
|
(6,666
|
)
|
|
|
2.97
|
|
Outstanding at September 30, 2018
|
|
|
946,500
|
|
|
$
|
2.80
|
|
|
|
834,335
|
|
|
$
|
2.69
|
|
|
|
112,165
|
|
|
$
|
3.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 30, 2018
|
|
|
946,500
|
|
|
$
|
2.80
|
|
|
|
834,335
|
|
|
$
|
2.69
|
|
|
|
112,165
|
|
|
$
|
3.57
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Vested
|
|
|
-
|
|
|
|
-
|
|
|
|
112,165
|
|
|
|
3.57
|
|
|
|
(112,165
|
)
|
|
|
3.57
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Forfeited or cancelled
|
|
|
(37,500
|
)
|
|
|
2.77
|
|
|
|
(37,500
|
)
|
|
|
2.77
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at September 29, 2019
|
|
|
909,000
|
|
|
$
|
2.80
|
|
|
|
909,000
|
|
|
$
|
2.80
|
|
|
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate Intrinsic Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2018
|
|
$
|
-
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate Intrinsic Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 29, 2019
|
|
$
|
-
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
As of September 29, 2019 and
September 30, 2018, there was no aggregate intrinsic value of the options outstanding because the
options’ exercise prices of $2.37 and $3.57 per share were greater than the average market prices of the common shares.
Option expense recognized was
$0 and $62,250 for the three months ended September 29, 2019 and September 30, 2018, respectively, and $44,166 and $255,631 for
the nine months ended September 29, 2019 and September 30, 2018, respectively. As of September 29, 2019, there was no unrecognized
compensation cost related to the options granted under the 2015 Stock Option Plan.
|
15.
|
Recent Accounting Standards
|
On February 25, 2016, the Financial
Accounting Standards Board issued a new standard, ASU No. 2016-02, “Leases,” on July 30, 2018, it issued ASU No. 2018-11,
“Leases (Topic 842): Targeted Improvements” and on March 5, 2019, it issued ASU No. 2019-01, “Leases (Topic 842):
Codification Improvements.” Under the new guidance, a lessee is required to recognize right-of-use (“ROU”) assets
and lease liabilities for leases with lease terms of more than 12 months. Consistent with previous U.S. generally accepted accounting
principles (“U.S. GAAP”), the recognition, measurement, and presentation of expenses and cash flows arising from a
lease by a lessee primarily depends on its classification as a finance or operating lease. However, unlike previous GAAP, which
required only finance leases to be recognized on the balance sheet, the new ASU requires both types of leases to be recognized
on the balance sheet. The Company adopted this standard on December 31, 2018. The Company elected to recognize and measure leases
at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings; however, no adjustment
to the opening balance of retained earnings was needed. The Company elected the available practical expedients for leases that
began before the effective date of this new standard except the Company did not elect to use hindsight in determining the lease
term and in assessing impairment of its ROU assets. The Company elected to apply and adopt as an accounting policy to exclude leases
with terms of 12 months or less but did not elect to apply and adopt as an accounting policy not to separate lease components from
non-lease components. The adoption of this standard for the year ending December 29, 2019 will have a significant effect on the
Company’s consolidated financial position as it records previously unrecorded operating leases but it will not have a significant
effect on its results of operations and cash flows.
On January 26, 2017, the Financial
Accounting Standards Board issued a new standard, ASU No. 2017-04, “Intangibles – Goodwill and Other – Simplifying
the Test for Goodwill Impairment.” The new standard modifies the concept of impairment from the condition that exists when
the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting
unit exceeds its fair value. It will be effective for the Company on December 30, 2019. The adoption of this standard is not expected
to have a significant effect on the Company’s consolidated financial position, results of operations and cash flows.
On August 28, 2018, the Financial
Accounting Standards Board issued a new standard, ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes
to the Disclosure Requirements for Fair Value Measurement.” The new standard modifies the disclosure requirements on fair
value measurements in Topic 820, “Fair Value Measurement.” Certain requirements were removed such as the amount of
and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, certain requirements were modified and certain
disclosures were added such as the changes in unrealized gains and losses for the period included in other comprehensive income
for recurring Level 3 fair value measurements held at the end of the reporting period. This standard will be effective for the
Company on December 30, 2019. Since this standard only revises disclosure requirements, the adoption of this standard will not
have a significant effect on the Company’s consolidated financial position, results of operations and cash flows.
|
16.
|
Loss per Common Share
|
The following table
sets forth the computation of loss per common share - basic and loss per common share – diluted for the three and
nine months ended September 29, 2019 and September 30, 2018:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss allocable to common
shareholders
|
|
$
|
(499,998
|
)
|
|
$
|
(10,118
|
)
|
|
$
|
(1,066,339
|
)
|
|
$
|
(156,549
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings per
share - weighted average shares
outstanding
|
|
|
18,680,030
|
|
|
|
18,690,030
|
|
|
|
18,684,938
|
|
|
|
18,690,030
|
|
Weighted average effect of dilutive
securities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Denominator for dilutive earnings
per share - weighted average shares
outstanding
|
|
|
18,680,030
|
|
|
|
18,690,030
|
|
|
|
18,684,938
|
|
|
|
18,690,030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Loss Per Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss allocable to common
shareholders
|
|
$
|
(0.03
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.01
|
)
|
Effect of dilutive securities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Net loss allocable to common
shareholders
|
|
$
|
(0.03
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.01
|
)
|
Due to the net
loss for the three and nine months ended September 29, 2019 and the three and nine months ended September 30, 2018, the calculations
of basic and diluted loss per share were the same since including options to purchase shares of common stock in the calculations
of diluted loss per share would have been anti-dilutive. However, if diluted earnings per share had been reported for the three
and nine months ended September 29, 2019, the calculations would have excluded options to purchase 909,000 shares of common stock
and for the three and nine months ended September 30, 2018, the calculations would have excluded options to purchase 946,500 shares
of common stock because the options’ exercise prices of $2.37 and $3.57 per share were greater than the average market prices
of the common shares.
The Company recognizes revenue
and related accounts receivable when obligations under the terms of a contract with a customer are satisfied, which includes the
control of products transferring to the customer. For Uniroyal, this generally occurs when products are shipped and, for UGL, this
generally occurs when the customer accepts delivery either at the Company’s U.K. facility or at a mutually agreed upon location.
Revenue is measured as the amount of consideration the Company expects to receive in exchange for products transferred to the customer.
A contract asset occurs when an entity transfers products to a customer before payment is due while a contract liability occurs
when an entity has an obligation to transfer products to a customer for which the entity has already received payment (or payment
is due) from the customer. Remaining performance obligations exist when an entity expects to record future revenue on partially
completed contracts. The Company does not have contract assets or contract liabilities and has no remaining performance obligations
since it does not recognize revenue until a contract is complete.
The following table
sets forth revenue disaggregated by the Company’s automotive and industrial sectors for the three and nine months
ended September 29, 2019 and September 30, 2018:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
Revenue by product sector:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automotive sector
|
|
$
|
14,133,223
|
|
|
$
|
15,704,983
|
|
|
$
|
46,433,893
|
|
|
$
|
50,779,733
|
|
Industrial sector
|
|
|
7,900,316
|
|
|
|
8,617,549
|
|
|
|
25,089,289
|
|
|
|
25,995,719
|
|
Total Revenue
|
|
$
|
22,033,539
|
|
|
$
|
24,322,532
|
|
|
$
|
71,523,182
|
|
|
$
|
76,775,452
|
|
The following table
sets forth revenue disaggregated by the geographic locations of the Company’s customers for the three and nine months
ended September 29, 2019 and September 30, 2018:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
|
September 29,
2019
|
|
|
September 30,
2018
|
|
Revenue by customer location:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
11,213,393
|
|
|
$
|
12,024,258
|
|
|
$
|
35,527,931
|
|
|
$
|
35,925,458
|
|
Europe
|
|
|
9,362,032
|
|
|
|
11,088,469
|
|
|
|
31,968,702
|
|
|
|
36,253,258
|
|
Asia
|
|
|
1,383,081
|
|
|
|
1,128,556
|
|
|
|
3,799,104
|
|
|
|
4,381,679
|
|
Other
|
|
|
75,033
|
|
|
|
81,249
|
|
|
|
227,445
|
|
|
|
215,057
|
|
Total Revenue
|
|
$
|
22,033,539
|
|
|
$
|
24,322,532
|
|
|
$
|
71,523,182
|
|
|
$
|
76,775,452
|
|
|
18.
|
Restructuring Expenses
|
In order to increase operating
efficiencies and decrease costs, the Company developed a plan to restructure the operations and the management team of its foreign
operations located in Earby, England. As part of this restructuring, the Company announced the decommissioning of the calender
operations which could not be economically modernized. An impairment charge of $510,230 for the assets used in this operation was
included in the operating results for the year ended December 30, 2018. The decommissioning plan was implemented over an extended
period to permit existing customers time to arrange for alternate sources of product or for them to switch to one of the Company’s
other coated fabric solutions from its state-of-the art production facility. The final calender run was in August 2019. The Company
anticipated that it would reduce its work force but would also offer a retraining program to allow a limited number of employees
the opportunity to move to other production areas within the facility. The Company does not expect that the cost associated with
this aspect of the plan to be significant and will expense these costs as incurred. Also, as part of the restructuring, during
the quarter ended March 31, 2019 the Company entered into settlement agreements with certain members of that facility’s management
team which terminated their continuing service. The Company recorded a charge of $343,003 for the cost of these agreements which
is included in Other Operating Expenses in the accompanying consolidated statements of operations for the nine months ended September
29, 2019.
The Company has evaluated subsequent
events occurring through the date that the financial statements were available to be issued for events requiring recording or
disclosure in the September 29, 2019 consolidated financial statements. There were no material events or transactions occurring
during this period requiring recognition or disclosure.
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Business Description
We are a leading provider of manufactured
vinyl coated fabrics. Our best-known brand, Naugahyde, is the product of many improvements on a rubber-coated fabric developed
a century ago in Naugatuck, Connecticut. We design, manufacture and market a wide selection of vinyl coated fabric products under
a portfolio of recognized brand names. We believe that our business has continued to be a leading supplier in its marketplace because
of our ability to provide specialized materials with performance characteristics customized to the end-user specifications, complemented
by technical and customer support for the use of our products in manufacturing.
Our vinyl coated fabric products have undergone
considerable evolution and today are distinguished by superior performance in a wide variety of applications as alternatives to
leather, cloth and other synthetic fabric coverings. Our standard product lines consist of more than 600 SKUs with combinations
of colors, textures, patterns and other properties. Our products are differentiated by unique protective top finishes and transfer
print capabilities. Additional process capabilities include embossing grains and patterns, and rotogravure printing, which imparts
five color character prints and non-registered prints, lamination and panel cutting.
Our vinyl coated fabric products have various
high-performance characteristics and capabilities. They are durable, stain resistant, easily processed, more cost-effective and
better performing than traditional leather or fabric coverings. Our products are frequently used in applications that require rigorous
performance characteristics such as automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial
and hospitality seating, healthcare facilities and athletic equipment. We manufacture materials in a wide range of colors and textures.
They can be hand or machine sewn, laminated to an underlying structure, thermoformed to cover various substrates or made into a
variety of shapes for diverse end-uses. We are a long-established supplier to the global automotive industry and manufacture products
for interior soft trim components from floor to headliner, which are produced to meet specific component production requirements
such as cut and sew, vacuum forming/covering, compression molding, and high frequency welding. Some products are supplied with
micro perforations, which are necessary on most compression molding processes. Materials can also be combined with polyurethane
or polypropylene foam laminated by either flame or hot melt adhesive for seating, fascia and door applications.
Products are developed and marketed based
upon the performance characteristics required by end-users. For example, for recreational products used outdoors, such as boats,
personal watercraft, golf carts and snowmobiles, a product designed primarily for water-based durability and weatherability is
used. We also manufacture a line of products called BeautyGard®, with water-based topcoats that contain agents to
protect against bacterial and fungal micro-organisms and can withstand repeated cleaning, a necessity in the restaurant and health
care industries. These topcoats are environmentally friendlier than solvent-based topcoats. The line is widely used in hospitals
and other healthcare facilities. Flame and smoke retardant vinyl coated fabrics are used for a variety of commercial and institutional
furniture applications, including hospitals, restaurants and residential care centers and seats for school buses, trains and aircraft.
We currently conduct our operations in
manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.
Critical Accounting Policies and Estimates
The preparation of our consolidated financial
statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires
management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and
related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based
upon historical experience and various other factors and circumstances. We believe that our estimates and assumptions are reasonable
under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances.
For further discussion of our significant accounting policies, refer to Note 1 – “Summary of Significant Accounting
Policies” to the consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations – Critical Accounting Policies, Judgments and Estimates” in our Annual Report on Form 10-K
for the fiscal year ended December 30, 2018.
Recent Accounting Pronouncements
See Note 15 – “Recent Accounting
Standards” to the consolidated financial statements for a discussion of recent accounting guidance.
Overview:
The Company and its subsidiaries use a
52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending December 29, 2019 and the prior year
ended December 30, 2018 are 52-week years.
Our Earby, England operation’s functional
currency is the British Pound Sterling and has sales and purchases transactions that are denominated in currencies other than the
Pound Sterling, principally the Euro. Approximately 28% of the Company’s global revenues and 32% of its global raw material
purchases are derived from these Euro transactions.
The average year-to-date exchange rate
for the Pound Sterling to the U.S. Dollar was approximately 5.8% lower and the average exchange rate for the Euro to the Pound
Sterling was approximately 0.1% lower in 2019 compared to 2018. These exchange rate changes had the effect of decreasing net sales
by approximately $2.3 million for the nine months ended September 29, 2019. The overall currency effect on the Company’s
net loss was a negative amount of approximately $57,000 for the nine months ended September 29, 2019.
Three Months Ended September 29, 2019
Compared to the Three Months Ended September 30, 2018
The following table sets forth, for the
three months ended September 29, 2019 (“three months 2019”) and September 30, 2018 (“three months 2018”),
certain operational data including their respective percentage of net sales:
|
|
Three Months Ended
|
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
Change
|
|
|
%
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
22,033,539
|
|
|
|
100.0
|
%
|
|
$
|
24,322,532
|
|
|
|
100.0
|
%
|
|
$
|
(2,288,993
|
)
|
|
|
-9.4
|
%
|
Cost of Sales
|
|
|
18,471,639
|
|
|
|
83.8
|
%
|
|
|
20,112,796
|
|
|
|
82.7
|
%
|
|
|
(1,641,157
|
)
|
|
|
-8.2
|
%
|
Gross Profit
|
|
|
3,561,900
|
|
|
|
16.2
|
%
|
|
|
4,209,736
|
|
|
|
17.3
|
%
|
|
|
(647,836
|
)
|
|
|
-15.4
|
%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
1,061,781
|
|
|
|
4.8
|
%
|
|
|
1,075,064
|
|
|
|
4.4
|
%
|
|
|
(13,283
|
)
|
|
|
-1.2
|
%
|
General and administrative
|
|
|
1,373,118
|
|
|
|
6.2
|
%
|
|
|
1,587,656
|
|
|
|
6.5
|
%
|
|
|
(214,538
|
)
|
|
|
-13.5
|
%
|
Research and development
|
|
|
377,989
|
|
|
|
1.7
|
%
|
|
|
408,256
|
|
|
|
1.7
|
%
|
|
|
(30,267
|
)
|
|
|
-7.4
|
%
|
Total Operating Expenses
|
|
|
2,812,888
|
|
|
|
12.8
|
%
|
|
|
3,070,976
|
|
|
|
12.6
|
%
|
|
|
(258,088
|
)
|
|
|
-8.4
|
%
|
Operating Income
|
|
|
749,012
|
|
|
|
3.4
|
%
|
|
|
1,138,760
|
|
|
|
4.7
|
%
|
|
|
(389,748
|
)
|
|
|
-34.2
|
%
|
Interest expense
|
|
|
(509,829
|
)
|
|
|
-2.3
|
%
|
|
|
(488,905
|
)
|
|
|
-2.0
|
%
|
|
|
(20,924
|
)
|
|
|
4.3
|
%
|
Other income (expense)
|
|
|
50,213
|
|
|
|
0.2
|
%
|
|
|
(22,956
|
)
|
|
|
-0.1
|
%
|
|
|
73,169
|
|
|
|
<-100
|
%
|
Income before Taxes
|
|
|
289,396
|
|
|
|
1.3
|
%
|
|
|
626,899
|
|
|
|
2.6
|
%
|
|
|
(337,503
|
)
|
|
|
-53.8
|
%
|
Tax provision (benefit)
|
|
|
12,022
|
|
|
|
0.1
|
%
|
|
|
(132,670
|
)
|
|
|
-0.5
|
%
|
|
|
144,692
|
|
|
|
<-100
|
%
|
Net Income
|
|
|
277,374
|
|
|
|
1.3
|
%
|
|
|
759,569
|
|
|
|
3.1
|
%
|
|
|
(482,195
|
)
|
|
|
-63.5
|
%
|
Preferred dividends
|
|
|
(777,372
|
)
|
|
|
-3.5
|
%
|
|
|
(769,687
|
)
|
|
|
-3.2
|
%
|
|
|
(7,685
|
)
|
|
|
1.0
|
%
|
Net Loss Allocable to Common Shareholders
|
|
$
|
(499,998
|
)
|
|
|
-2.3
|
%
|
|
$
|
(10,118
|
)
|
|
|
0.0
|
%
|
|
$
|
(489,880
|
)
|
|
|
>100
|
%
|
Revenue:
Total revenue for the three months 2019
decreased $2,288,993 or 9.4% to $22,033,539 from $24,322,532 for the three months 2018. Excluding the negative currency effect
of approximately $544,000 from the change in exchange rates, total revenue would have decreased by approximately $1.7 million or
7.2%. U.S. automotive sales for the three months 2019 decreased 6.7% compared to the three months 2018 resulting from a slowing
of new automotive programs during the three months 2019. European automotive sales decreased 6.4% compared to the prior year excluding
the currency adjustment. Sales for the three months 2019 for the industrial sector decreased 8.3% (7.6% before currency effect)
compared to the three months 2018 primarily due to a decline in the U.S. contract market.
Gross Profit:
Total gross profit for the three months
2019 decreased $647,836 or 15.4% to $3,561,900 from $4,209,736 for the three months 2018. The gross profit percentage was 16.2%
of sales for the three months 2019 compared to 17.3% for the three months 2018. Although raw material pricing during 2019 has been
relatively flat and in some cases slightly down from the beginning of the year, raw material prices were generally higher for the
three months 2019 compared to 2018. This had a negative impact on the gross profit amount and percentage in 2019. Also having a
negative impact were the effects of product mix. To offset raw material price increases, the Company increased prices during the
first three months of 2019 in several of its markets. The decrease in gross profit included a negative net currency effect of $54,000.
Excluding this effect, gross profit would have declined by 14.1%.
Operating Expenses:
Selling expenses for the three months 2019
decreased $13,283 or 1.2% to $1,061,781 from $1,075,064 for the three months 2018. The decrease was primarily due to the favorable
currency effect of $25,000. This decrease was partially offset by net increases in employment related costs.
General and administrative expenses for
the three months 2019 decreased $214,538 or 13.5% to $1,373,118 from $1,587,656 for the three months 2018. This decrease was primarily
attributable to a decrease in employment costs and professional fees for the three months 2019 compared to the three months 2018.
Also contributing to the decrease was the favorable currency effect of $47,000.
Research and development expenses for the
three months 2019 decreased $30,267 or 7.4% to $377,989 from $408,256 for the three months 2018. The decrease was principally attributable
to lower employment costs and the favorable currency effect of $11,000. This decrease was partially offset by an increase in development
costs for new trials.
Operating Income:
Operating income for the three months 2019
decreased $389,748 or 34.2% to $749,012 from $1,138,760 for the three months 2018. The operating income percentage was 3.4% of
sales for the three months 2019 compared to 4.7% for the three months 2018. Operating income decreased from the decrease in gross
profit which was partially offset by the decrease in operating expenses.
Interest Expense:
Interest expense for the three months 2019
increased $20,924 or 4.3% to $509,829 from $488,905 for the three months 2018. The increase was primarily due to new equipment
purchases and higher interest rates on LIBOR and prime during the three months 2019 partially offset by debt repayments compared
to the three months 2018.
Other Income (Expense):
Other income for the three months 2019
was $50,213 compared to other expense of $22,956 for the three months 2018. Included in other income (expense) are the currency
gains and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities
that are denominated in Euros as these currencies fluctuated during the quarter. Also included in other income (expense) are gains
and losses from the change in fair values on the Company’s foreign currency exchange contracts.
Tax Provision (Benefit):
The Company files income tax returns in
the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s U.S. operating
subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses,
and credits are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company,
which issued preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income
is allocated entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to
the sellers of Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred
ownership interests is reported to the sellers who report it on their respective individual tax returns.
For the three months 2019, the tax provision was $12,022 compared
to a tax benefit of $132,670 for the three months 2018. The tax provision for the three months 2019 was principally attributable
to the results of the U.S. operations while the tax benefit for the three months 2018 was principally attributable to the results
of the U.K. operations partially offset by a tax provision for the U.S. operations.
Preferred Stock Dividend:
The terms of the acquisitions in November
2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers.
These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to
7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary
of the issuance up to a maximum of 8.0%.
Nine Months Ended September 29, 2019
Compared to the Nine Months Ended September 30, 2018
The following table sets forth, for the
nine months ended September 29, 2019 (“nine months 2019”) and September 30, 2018 (“nine months 2018”),
certain operational data including their respective percentage of net sales:
|
|
Nine Months Ended
|
|
|
|
September 29, 2019
|
|
|
September 30, 2018
|
|
|
Change
|
|
|
%
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
71,523,182
|
|
|
|
100.0
|
%
|
|
$
|
76,775,452
|
|
|
|
100.0
|
%
|
|
$
|
(5,252,270
|
)
|
|
|
-6.8
|
%
|
Cost of Sales
|
|
|
59,434,689
|
|
|
|
83.1
|
%
|
|
|
63,184,044
|
|
|
|
82.3
|
%
|
|
|
(3,749,355
|
)
|
|
|
-5.9
|
%
|
Gross Profit
|
|
|
12,088,493
|
|
|
|
16.9
|
%
|
|
|
13,591,408
|
|
|
|
17.7
|
%
|
|
|
(1,502,915
|
)
|
|
|
-11.1
|
%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
3,348,622
|
|
|
|
4.7
|
%
|
|
|
3,624,145
|
|
|
|
4.7
|
%
|
|
|
(275,523
|
)
|
|
|
-7.6
|
%
|
General and administrative
|
|
|
4,332,978
|
|
|
|
6.1
|
%
|
|
|
5,194,622
|
|
|
|
6.8
|
%
|
|
|
(861,644
|
)
|
|
|
-16.6
|
%
|
Research and development
|
|
|
1,302,707
|
|
|
|
1.8
|
%
|
|
|
1,260,784
|
|
|
|
1.6
|
%
|
|
|
41,923
|
|
|
|
3.3
|
%
|
Other operating expenses
|
|
|
343,003
|
|
|
|
0.5
|
%
|
|
|
-
|
|
|
|
0.0
|
%
|
|
|
343,003
|
|
|
|
-
|
|
Total Operating Expenses
|
|
|
9,327,310
|
|
|
|
13.0
|
%
|
|
|
10,079,551
|
|
|
|
13.1
|
%
|
|
|
(752,241
|
)
|
|
|
-7.5
|
%
|
Operating Income
|
|
|
2,761,183
|
|
|
|
3.9
|
%
|
|
|
3,511,857
|
|
|
|
4.6
|
%
|
|
|
(750,674
|
)
|
|
|
-21.4
|
%
|
Interest expense
|
|
|
(1,547,343
|
)
|
|
|
-2.2
|
%
|
|
|
(1,418,932
|
)
|
|
|
-1.8
|
%
|
|
|
(128,411
|
)
|
|
|
9.0
|
%
|
Other income (expense)
|
|
|
53,396
|
|
|
|
0.1
|
%
|
|
|
(8,894
|
)
|
|
|
0.0
|
%
|
|
|
62,290
|
|
|
|
<-100
|
%
|
Income before Taxes
|
|
|
1,267,236
|
|
|
|
1.8
|
%
|
|
|
2,084,031
|
|
|
|
2.7
|
%
|
|
|
(816,795
|
)
|
|
|
-39.2
|
%
|
Tax benefit
|
|
|
(6,287
|
)
|
|
|
0.0
|
%
|
|
|
(89,670
|
)
|
|
|
-0.1
|
%
|
|
|
83,383
|
|
|
|
-93.0
|
%
|
Net Income
|
|
|
1,273,523
|
|
|
|
1.8
|
%
|
|
|
2,173,701
|
|
|
|
2.8
|
%
|
|
|
(900,178
|
)
|
|
|
-41.4
|
%
|
Preferred dividends
|
|
|
(2,339,862
|
)
|
|
|
-3.3
|
%
|
|
|
(2,330,250
|
)
|
|
|
-3.0
|
%
|
|
|
(9,612
|
)
|
|
|
0.4
|
%
|
Net Loss Allocable to Common Shareholders
|
|
$
|
(1,066,339
|
)
|
|
|
-1.5
|
%
|
|
$
|
(156,549
|
)
|
|
|
-0.2
|
%
|
|
$
|
(909,790
|
)
|
|
|
>100
|
%
|
Revenue:
Total revenue for the nine months 2019
decreased $5,252,270 or 6.8% to $71,523,182 from $76,775,452 for the nine months 2018. Excluding the negative currency effect of
the exchange rates, total revenue would have decreased by approximately $3.0 million or 3.9%. U.S. automotive sales for the nine
months 2019 decreased slightly (0.2%) compared to the nine months 2018. European automotive sales decreased 6.4% compared to the
prior year excluding the currency adjustment. Sales for the nine months 2019 for the industrial sector decreased 3.5% (2.5% before
currency effect) compared to the nine months 2018 primarily due to a decline in the U.S. contract market.
Gross Profit:
Total gross profit for the nine months
2019 decreased $1,502,915 or 11.1% to $12,088,493 from $13,591,408 for the nine months 2018. The gross profit percentage was 16.9%
of sales for the nine months 2019 compared to 17.7% for the nine months 2018. Although raw material pricing during 2019 has been
relatively flat and in some cases slightly down from the beginning of the year, raw material prices were generally higher for the
nine months 2019 compared to 2018. This had a negative impact on the gross profit amount and percentage in 2019. Also having a
negative impact were the effects of product mix. To offset raw material price increases, the Company increased prices during the
first three months of 2019 in several of its markets. The decrease in gross profit included a negative net currency effect of $326,000.
Excluding this effect, gross profit would have declined by 8.7%.
Operating Expenses:
Selling expenses for the nine months 2019
decreased $275,523 or 7.6% to $3,348,622 from $3,624,145 for the nine months 2018. The Company pays commissions only on certain
U.K. automotive programs. In conjunction with the decline in total automotive sales in the U.K. for the nine months 2019, there
was a decrease in commissionable sales. The decrease in selling expense for the nine months 2019 was principally attributable to
the lower commissions related to these sales. Also contributing to the decrease was the favorable currency effect of $104,000.
This decrease was partially offset by increases in employment related costs.
General and administrative expenses for
the nine months 2019 decreased $861,644 or 16.6% to $4,332,978 from $5,194,622 for the nine months 2018. This decrease was primarily
attributable to a decrease in employment costs for the nine months 2019 compared to the nine months 2018. Also contributing to
the decrease was the favorable currency effect of $157,000.
Research and development expenses for the
nine months 2019 increased $41,923 or 3.3% to $1,302,707 from $1,260,784 for the nine months 2018. The increase was principally
attributable to development costs for new trials which was partially offset by the favorable currency effect of $43,000.
Other operating expenses for the nine months
2019 was $343,003. There was not a corresponding amount for the nine months 2018. This amount was cost incurred by the Company
as part of a restructuring plan to reduce inefficiencies at its U.K. facility.
Operating Income:
Operating income for the nine months 2019
decreased $750,674 or 21.4% to $2,761,183 from $3,511,857 for the nine months 2018. The operating income percentage was 3.9% of
sales for the nine months 2019 compared to 4.6% for the nine months 2018. Operating income decreased from the decrease in gross
profit which was partially offset by the decrease in operating expenses.
Interest Expense:
Interest expense for the nine months 2019
increased $128,411 or 9.0% to $1,547,343 from $1,418,932 for the nine months 2018. The increase was primarily due to new equipment
purchases and higher interest rates on LIBOR and prime during the nine months 2019 partially offset by debt repayments compared
to the nine months 2018.
Other Income (Expense):
Other income for the nine months 2019 was
$53,396 compared to other expense of $8,894 for the nine months 2018. Included in other income (expense) are the currency gains
and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that
are denominated in Euros as these currencies fluctuated during the year. Also included in other income (expense) are gains and
losses from the change in fair values on the Company’s foreign currency exchange contracts.
Tax Benefit:
The Company files income tax returns in
the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s subsidiary,
Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses, and credits
are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company, which issued
preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income is allocated
entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to the sellers of
Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred ownership
interests is reported to the sellers who report it on their respective individual tax returns.
For the nine months 2019, the tax benefit
was $6,287 compared to $89,670 for the nine months 2018. The tax benefit for 2019 and 2018 were principally attributable to the
results of the U.K. operations partially offset by a tax provision for the U.S. operations.
Preferred Stock Dividend:
The terms of the acquisitions in November
2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers.
These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to
7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary
of the issuance up to a maximum of 8.0%.
Liquidity and Sources of Capital
Cash, as it is needed, is provided by using
the Company’s lines of credit. These lines provide for a total borrowing commitment in excess of $42,000,000 subject to the
underlying borrowing base specified in the agreements. Of the total outstanding borrowings of $20,936,172 at September 29, 2019,
$15.2 million of the lines bears interest at LIBOR or the Eurodollar rate plus a range of 1.95% to 2.45%, depending on the underlying
borrowing base and $5.7 million bears interest at the bank’s prime or base lending rate which was 5.25% at September 29,
2019. At September 29, 2019, the lines provided an additional availability of approximately $2.6 million. We plan to use this availability
and cash provided by operating activities to finance our cash needs for the remaining months of fiscal 2019 and future periods.
The balances due under the lines of credit are recorded as current liabilities on the consolidated balance sheets.
Given our capital resources in the U.S.
and the potential for increased investment and acquisitions in foreign jurisdictions, we did not have a history of repatriating
a significant portion of our foreign cash. Accordingly, we had not recognized a deferred tax liability for these unremitted earnings.
However, the Tax Cuts and Jobs Act of 2017 imposed a one-time transition tax on deemed repatriation of deferred foreign income,
which the Company recorded in tax expense in 2017. In the event that we decide to repatriate these foreign amounts to fund U.S.
operations, the Company will not be required to pay any additional U.S. tax related to these amounts.
The ratio of current assets to current
liabilities, including the amount due under our lines of credit, was 0.92 at September 29, 2019 and 0.97 at December 30, 2018.
Cash balances decreased $187,803, net of
the effects of currency translation of $22,749, to $818,289 at September 29, 2019 from $1,028,841 at December 30, 2018. Of the
above noted amounts, $769,000 and $923,071 were held outside the U.S. by our foreign subsidiaries as of September 29, 2019 and
December 30, 2018, respectively.
Cash provided by operations was $2,455,877
for the nine months 2019 compared to $4,920,822 provided by operations for the nine months 2018. For the nine months 2019, cash
provided by operations was primarily due to adjustments for non-cash items of $1,656,649, net income of $1,273,523 and changes
in other assets and liabilities of $48,683 offset by changes in working capital of $(522,978). For the nine months 2018, cash provided
by operations was primarily due to net income of $2,173,701, adjustments for non-cash items of $1,853,440 and changes in working
capital of $998,178, offset by cash flows related to changes in other assets and liabilities of $(104,497).
Cash used in investing activities was
$1,457,071 for the nine months 2019 compared to $3,185,555 for the nine months 2018. During 2019 and 2018, cash used in
investing activities was principally for purchases of machinery and equipment at our manufacturing locations and payments
made for company-owned key man life insurance premiums. For the nine months 2019, the payments made for the life insurance
premiums were offset by proceeds from policy loans of $249,051.
For the nine months 2019, cash used in
financing activities was $1,186,609 compared to $1,808,121 used in financing activities for the nine months 2018. Impacting cash
flows from financing activities for the nine months 2019 and 2018 were net advances on lines of credit of $1,893,069 and $936,673,
respectively. The increases in advances on the lines of credit were used to fund working capital. Also included in cash flows from
financing activities were preferred dividend payments of $2,332,503 and $2,325,640 during the nine months 2019 and 2018, respectively.
During the nine months 2019 and 2018, our majority shareholder provided $800,000 and $272,000, respectively, in financing in the
form of subordinated secured promissory notes. Payments of $550,000 and $47,000 were made on these notes during the nine months
2019 and 2018, respectively. During the nine months 2019 and 2018, we drew $454,088 and $560,677, respectively, on equipment financing
commitments from our bank to finance asset purchases.
Our credit agreements contain customary
affirmative and negative covenants. We were in compliance with our debt covenants as of September 29, 2019 and through the date
of filing of this report.
We currently have several on-going capital
projects that are important to our long-term strategic goals. Machinery and equipment will also be added as needed to increase
capacity or enhance operating efficiencies in our manufacturing plants. We will use a combination of financing arrangements to
provide the necessary capital. We believe that our existing resources, including cash on hand and our credit facilities, together
with cash generated from operations and additional bank borrowings, will be sufficient to fund our cash flow requirements through
at least the next twelve months. However, there can be no assurance that additional financing will be available on favorable terms,
if at all.
We have no material off balance sheet arrangements.